End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24,850 KRW | -0.20% | -0.80% | -7.96% |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
Business Summary
Number of employees: 665
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 262,522 | 100.0 % | 278,943 | 100.0 % | +6.26% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
91.5
%
| 237,618 | 90.5 % | 255,194 | 91.5 % | +7.40% |
Overseas (Others)
4.6
%
| 15,098 | 5.8 % | 12,859 | 4.6 % | -14.83% |
Philippines
2.5
%
| 4,694 | 1.8 % | 6,881 | 2.5 % | +46.61% |
Vietnam
1.4
%
| 5,112 | 1.9 % | 4,009 | 1.4 % | -21.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Duk-Young Kang
CEO | Chief Executive Officer | 77 | - |
Won-Tae Jeong
BRD | Director/Board Member | 61 | - |
Hyung-Rae Kim
BRD | Director/Board Member | 69 | - |
Gui-Ja Kim
BRD | Director/Board Member | 67 | - |
In-Cheol Choi
PRN | Corporate Officer/Principal | 61 | - |
Yeon-Woong Choi
PRN | Corporate Officer/Principal | 55 | - |
Yong-Woo Cho
PRN | Corporate Officer/Principal | 64 | - |
Jin-Ho Cho
PRN | Corporate Officer/Principal | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Duk-Young Kang
CEO | Chief Executive Officer | 77 | - |
Gui-Ja Kim
BRD | Director/Board Member | 67 | - |
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Hyung-Rae Kim
BRD | Director/Board Member | 69 | - |
Won-Tae Jeong
BRD | Director/Board Member | 61 | - |
Won-Il Kal
BRD | Director/Board Member | 67 | - |
Gun-Wook Kang
BRD | Director/Board Member | 54 | - |
Jeong-Tae Ju
BRD | Director/Board Member | 64 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,333,822 | 8,560,841 ( 52.41 %) | 1,622,553 ( 9.934 %) | 52.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
KOREA UNITED PHARM INC. 9.92% | 1,620,980 | 9.92% | 28,969,117 $ |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-7.96% | 268M | |
+20.44% | 44.39B | |
+20.08% | 22.46B | |
+18.77% | 15.04B | |
+19.27% | 13.98B | |
+56.16% | 13.15B | |
-10.55% | 6.89B | |
-0.05% | 6.79B | |
+14.03% | 5.71B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A033270 Stock
- Company Korea United Pharm Inc.